These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 20570598)
1. Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo. Wu YL; Huang J; Xu J; Liu J; Feng Z; Wang Y; Lai Y; Wu ZR Regul Pept; 2010 Sep; 164(2-3):83-9. PubMed ID: 20570598 [TBL] [Abstract][Full Text] [Related]
2. Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice. Xu F; Wang KY; Wang N; Li G; Liu D PLoS One; 2017; 12(7):e0181939. PubMed ID: 28750064 [TBL] [Abstract][Full Text] [Related]
3. A mutated glucagon-like peptide-1 with improved glucose-lowering activity in diabetic mice. Gao M; Tong Y; Gao X; Yao W J Pharm Pharmacol; 2013 Apr; 65(4):539-46. PubMed ID: 23488782 [TBL] [Abstract][Full Text] [Related]
4. Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42). Qin Z; Sun Z; Huang J; Hu Y; Wu Z; Mei B Neurosci Lett; 2008 Oct; 444(3):217-21. PubMed ID: 18760331 [TBL] [Abstract][Full Text] [Related]
5. Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes. Kim YM; Lee SM; Chung HS BMB Rep; 2013 Dec; 46(12):606-10. PubMed ID: 24195794 [TBL] [Abstract][Full Text] [Related]
6. Development, characterization, and evaluation of a fusion protein of a novel glucagon-like peptide-1 (GLP-1) analog and human serum albumin in Pichia pastoris. Gao Z; Bai G; Chen J; Zhang Q; Pan P; Bai F; Geng P Biosci Biotechnol Biochem; 2009 Mar; 73(3):688-94. PubMed ID: 19270384 [TBL] [Abstract][Full Text] [Related]
8. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice. Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Green BD; Gault VA; O'Harte FP; Flatt PR Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953 [TBL] [Abstract][Full Text] [Related]
10. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats. Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721 [TBL] [Abstract][Full Text] [Related]
11. Bioactivity of a modified human Glucagon-like peptide-1. Xu F; Wang KY; Wang N; Li G; Liu D PLoS One; 2017; 12(2):e0171601. PubMed ID: 28152036 [TBL] [Abstract][Full Text] [Related]
12. Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels. Willard JR; Barrow BM; Zraika S Diabetologia; 2017 Apr; 60(4):701-708. PubMed ID: 27933334 [TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Lee YS; Jun HS Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094 [TBL] [Abstract][Full Text] [Related]
15. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness. Islam MS; Rahman SA; Mirzaei Z; Islam KB Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594 [TBL] [Abstract][Full Text] [Related]
16. A GLP-1 receptor agonist conjugated to an albumin-binding domain for extended half-life. Lindgren J; Refai E; Zaitsev SV; Abrahmsén L; Berggren PO; Karlström AE Biopolymers; 2014 May; 102(3):252-9. PubMed ID: 24549714 [TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ Diabetologia; 1998 Mar; 41(3):271-8. PubMed ID: 9541166 [TBL] [Abstract][Full Text] [Related]
18. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition. Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs. Eng H; Sharma R; McDonald TS; Landis MS; Stevens BD; Kalgutkar AS Xenobiotica; 2014 Sep; 44(9):842-8. PubMed ID: 24588343 [TBL] [Abstract][Full Text] [Related]
20. Recombinant production of mGLP-1 by coupling of refolding and intein-mediated self-cleavage (CRIS). Gao M; Tong Y; Tian H; Gao X; Yao W Appl Microbiol Biotechnol; 2012 Dec; 96(5):1283-90. PubMed ID: 22644527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]